VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LFCR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LFCRLifecore Biomedical, Inc.
$4.96$186M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLFCRQuarterly Financials

Lifecore Biomedical, Inc. (LFCR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lifecore Biomedical, Inc. (LFCR) quarterly income statement — complete revenue, gross profit & net income history

LFCR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue23.19M44.41M31.11M36.44M35.15M32.56M24.7M37.89M35.7M30.15M24.52M25.52M26.54M21.86M23.72M47.63M37.4M43.45M41.63M139.83M
Revenue Growth %-34.02%36.38%25.92%-3.81%-1.54%8.01%0.75%48.45%34.55%37.9%3.36%-46.42%-29.05%-49.68%-43.02%-65.94%-16.31%-66.81%-69.31%-10.44%
Cost of Goods Sold18.73M28.51M23.32M22.46M25.31M21.48M19.32M20.61M23.81M20.19M21.79M17.11M17.99M16.18M17.75M36.3M24.53M28.74M31.2M115.03M
COGS % of Revenue80.76%64.2%74.96%61.63%71.99%65.96%78.19%54.41%66.69%66.98%88.88%67.03%67.79%74.03%74.8%76.22%65.6%66.14%74.94%82.26%
Gross Profit4.46M15.9M7.79M13.98M9.85M11.08M5.39M17.27M11.89M9.96M2.73M8.41M8.55M5.68M5.98M11.32M12.87M14.71M10.44M24.8M
Gross Margin %19.24%35.8%25.04%38.37%28.01%34.04%21.81%45.59%33.31%33.02%11.12%32.97%32.21%25.97%25.2%23.78%34.4%33.87%25.06%17.74%
Gross Profit Growth %-54.68%43.43%44.63%-19.05%-17.23%11.32%97.47%105.25%39.14%75.33%-54.37%-25.7%-33.56%-61.41%-42.7%-54.34%-10.91%-28.7%-36.17%2.96%
Operating Expenses9.13M13.56M10.86M8.65M18.87M13.04M16.97M15.12M12.79M11.44M11.34M9.65M15.08M11.03M9.25M50.27M21.43M10.57M13.18M23.57M
OpEx % of Revenue39.38%30.54%34.9%23.75%53.69%40.05%68.69%39.92%35.82%37.94%46.25%37.81%56.82%50.45%39%105.54%57.31%24.34%31.65%16.86%
Selling, General & Admin7.92M7.54M8.89M8.98M10.09M11.12M14.3M12.22M9.85M9.34M9.21M7.77M10.28M8.29M8.1M18.92M14.16M8.01M9.47M16.14M
SG&A % of Revenue34.14%16.98%28.59%24.64%28.71%34.15%57.89%32.27%27.58%30.99%37.54%30.44%38.74%37.92%34.16%39.72%37.87%18.44%22.75%11.54%
Research & Development1.22M2.3M1.96M2.1M2.04M1.92M2.19M2.16M2.17M2.1M2.15M2.61M2.23M2.18M2.21M2.06M2M1.86M1.87M2.58M
R&D % of Revenue5.25%5.17%6.31%5.77%5.82%5.91%8.85%5.7%6.08%6.96%8.75%10.22%8.42%9.96%9.32%4.32%5.35%4.27%4.5%1.84%
Other Operating Expenses01000K0-1000K1000K0483K738K771K0-10K-727K1000K563K-1000K1000K1000K707K1000K1000K
Operating Income-4.67M2.33M-3.07M5.33M-9.03M-1.96M-11.58M2.15M-895K-1.48M-8.61M-1.23M-6.53M-5.35M-3.27M-38.94M-8.57M4.14M-2.74M1.23M
Operating Margin %-20.14%5.26%-9.86%14.62%-25.68%-6.02%-46.89%5.67%-2.51%-4.92%-35.13%-4.84%-24.61%-24.48%-13.8%-81.76%-22.91%9.53%-6.59%0.88%
Operating Income Growth %48.26%219.14%73.52%147.88%-908.83%-32.1%-34.48%274.15%86.3%72.29%-163.1%96.83%23.77%-229.28%-19.4%-3260.8%-450.96%382.4%78.01%109.4%
EBITDA-2.36M5.89M-1.09M7.24M-6.95M85K-9.59M4.4M1.11M283K-6.45M1.66M-3.32M-2.41M1.08M-35.55M-5.04M10.04M2.31M6.29M
EBITDA Margin %-10.18%13.27%-3.49%19.87%-19.78%0.26%-38.82%11.62%3.11%0.94%-26.29%6.5%-12.5%-11.03%4.55%-74.63%-13.47%23.12%5.55%4.5%
EBITDA Growth %66.03%6834.12%88.68%64.53%-725.83%-69.96%-48.79%165.28%133.48%111.73%-696.85%104.67%34.14%-124.01%-53.29%-665.01%-167.87%208.32%131.39%177.94%
D&A (Non-Cash Add-back)2.31M3.56M1.98M1.91M2.08M2.04M1.99M2.25M2.01M1.77M2.17M2.89M3.21M2.94M4.35M3.4M3.53M5.91M5.05M5.06M
EBIT-4.67M2.33M-9.11M4.41M-9.3M-1.06M-10.89M-1.35M19.29M18.25M-8.58M-25.36M-6.43M-5.59M-3.47M-33.11M-2.62M4.24M-2.61M1.58M
Net Interest Income-7.22M-9.25M-493K-5.52M-5.48M-5.46M-5.37M-5.79M-4.29M-4.07M-3.94M-3.92M-4.83M-3.61M-3.23M-3.46M-4.08M-3.08M-6.65M-5M
Interest Income128K215K58K0000000015K00015K20K19K27K17K
Interest Expense7.35M9.46M551K5.52M5.48M5.46M5.37M5.79M4.29M4.07M3.94M3.93M4.83M3.61M3.23M3.48M4.11M3.09M6.68M5.02M
Other Income/Expense-10.27M-10.3M-6.59M-6.44M-5.75M-4.57M-4.67M-9.29M15.9M15.66M-3.91M-28.06M-4.73M-3.85M-3.43M2.35M1.84M-3M-6.54M-4.67M
Pretax Income-14.94M-7.97M-9.66M-1.11M-14.78M-6.53M-16.25M-7.14M15M14.18M-12.52M-29.29M-11.26M-9.2M-6.7M-36.59M-6.72M1.14M-9.28M-3.44M
Pretax Margin %-64.4%-17.94%-31.05%-3.06%-42.03%-20.05%-65.8%-18.85%42.02%47.02%-51.06%-114.78%-42.43%-42.06%-28.25%-76.83%-17.98%2.63%-22.3%-2.46%
Income Tax43K4K333K33K-8K43K-25K-57K217K-65K88K230K70K4K4K-827K-87K-3.08M-1.65M-575K
Effective Tax Rate %-0.29%-0.05%-3.45%-2.96%0.05%-0.66%0.15%0.8%1.45%-0.46%-0.7%-0.79%-0.62%-0.04%-0.06%2.26%1.29%-269.67%17.78%16.71%
Net Income-14.98M-7.97M-9.99M-1.15M-14.77M-6.57M-16.23M-7.08M15.63M14.22M-10.75M-35.57M-36.51M-12.81M-10.97M-36.66M-13.09M-38.44M-9.48M-2.87M
Net Margin %-64.59%-17.95%-32.12%-3.15%-42.01%-20.18%-65.7%-18.7%43.78%47.16%-43.85%-139.38%-137.58%-58.57%-46.22%-76.98%-34.99%-88.47%-22.76%-2.05%
Net Income Growth %-1.43%-21.29%38.44%83.81%-194.48%-146.22%-50.92%80.09%142.82%211.03%1.93%2.98%-178.98%66.69%-15.71%-1179.24%-138.01%-189.01%13.85%81.08%
Net Income (Continuing)-14.98M-7.97M-9.99M-1.15M-14.77M-6.57M-16.23M-7.09M14.79M14.24M-12.61M-29.52M-11.33M-9.2M-6.71M-35.77M-6.64M4.23M-7.63M-2.87M
Discontinued Operations00000003K847K-24K1000K-1000K-1000K-1000K-1000K-897K-1000K-1000K-1000K0
Minority Interest00000000000000000000
EPS (Diluted)-0.43-0.25-0.29-0.06-0.47-0.25-0.53-0.230.430.39-0.35-1.19-1.20-0.42-0.38-1.24-0.44-1.30-0.32-0.10
EPS Growth %8.51%0%45.28%75.96%-209.3%-164.1%-51.43%80.67%135.83%192.86%7.89%4.03%-172.73%67.69%-18.75%-1167.89%-131.58%-188.89%15.79%81.19%
EPS (Basic)-0.43-0.25-0.29-0.06-0.47-0.25-0.53-0.230.510.47-0.35-1.19-1.20-0.42-0.38-1.24-0.45-1.30-0.32-0.10
Diluted Shares Outstanding37.48M37.47M37.4M37.03M37.02M34.36M30.86M30.56M36.61M36.42M30.4M30.32M30.3M30.3M29.58M29.51M29.48M29.47M29.42M29.33M
Basic Shares Outstanding37.48M37.47M37.4M37.03M37.02M34.36M30.86M30.56M30.49M30.46M30.4M30.32M30.3M30.3M29.58M29.51M28.86M29.47M29.36M29.33M
Dividend Payout Ratio--------------------